Incidence of endophthalmitis after intravitreal injection: Is antibioprophylaxis mandatory?;Incidence de l'endophtalmie après injection intravitréenne: peut-on se passer de l'antibioprophylaxie ?

Journal Francais d'Ophtalmologie

Volumn 37, Issue 4, 2014, Pages 273-279

  Ramel, J C ^a   Bron, A M ^a   Isaico, R ^a   Meillon, C ^a   Binquet, C ^b   Creuzot Garcher, C ^a  

^a HÔPITAL DU BOCAGE   (France)

^b DIJON UNIVERSITY HOSPITAL   (France)

Author keywords

Antibioprophylaxis; Antibiotic; Endophthalmitis; Incidence; Infection; Intravitreal injection

Indexed keywords

ADVERSE EFFECTS; AGED; ANTIBIOTIC PROPHYLAXIS; ENDOPHTHALMITIS; FEMALE; HUMAN; INCIDENCE; INTRAVITREAL DRUG ADMINISTRATION; MALE; RETROSPECTIVE STUDY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTIBIOTIC PROPHYLAXIS; ENDOPHTHALMITIS; FEMALE; HUMANS; INCIDENCE; INTRAVITREAL INJECTIONS; MALE; RETROSPECTIVE STUDIES;

EID: 84897583468     PISSN: 01815512     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jfo.2014.01.003     Document Type: Article

References (45)

1. C.A. McCannel Meta-analysis of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents: causative organisms and possible prevention strategies Retina 31 2011 654 661
2. M.P. Simunovic, R.B. Rush, A.P. Hunyor, and A.A. Chang Endophthalmitis following intravitreal injection versus endophthalmitis following cataract surgery: clinical features, causative organisms and post-treatment outcomes Br J Ophthalmol 96 2012 862 866
3. L.P. Aiello, A.J. Brucker, S. Chang, E.T. Cunningham, D.J. D'Amico, and H.W. Flynn et al. Evolving guidelines for intravitreous injections Retina 24 2004 3 19
4. B. Bodaghi, J.F. Korobelnik, I. Cochereau, J. Hajjar, F. Goebel, and N. Dumarcet Injections intravitréennes: mise au point de l'Afssaps J Fr Ophtalmol 35 2012 69 71
5. I. Cochereau, J.F. Korobelnik, and B. Bodaghi Prévention de l'endophtalmie post-injection intravitréenne: l'antibioprophylaxie a-t-elle sa place ? J Fr Ophtalmol 36 2013 72 75
6. C.S. Cheung, A.W. Wong, A. Lui, P.J. Kertes, R. Devenyi, and W.C. GLam Incidence of endophthalmitis and use of antibiotic prophylaxis after intravitreal injections Ophthalmology 119 2012 1609 1614
7. R.A. Goldberg, H.W. Flynn, R.F. Isom, D. Miller, and S. Gonzalez An outbreak of streptococcus endophthalmitis after intravitreal injection of bevacizumab Am J Ophthalmol 153 2012 204 208
8. D.J. D'Amico, H.N. Masonson, M. Patel, A.P. Adamis, E.T. Cunningham, and D.R. Guyer et al. Pegaptanib sodium for neovascular age-related macular degeneration: two-year safety results of the two prospective, multicenter, controlled clinical trials Ophthalmology 113 2006 992 1001
9. P.J. Rosenfeld, D.M. Brown, J.S. Heier, D.S. Boyer, P.K. Kaiser, and C.Y. Chung et al. Ranibizumab for neovascular age-related macular degeneration N Engl J Med 355 2006 1419 1431
10. D.M. Brown, M. Michels, P.K. Kaiser, J.S. Heier, J.P. Sy, and T. Ianchulev Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: two-year results of the ANCHOR study Ophthalmology 116 2009 57 65
11. C.P. Shah, S.J. Garg, J.F. Vander, G.C. Brown, R.S. Kaiser, and J.A. Haller Outcomes and risk factors associated with endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents Ophthalmology 118 2011 2028 2034
12. M. Englander, T.C. Chen, E.I. Paschalis, J.W. Miller, and I.K. Kim Intravitreal injections at the Massachusetts Eye and Ear Infirmary: analysis of treatment indications and postinjection endophthalmitis rates Br J Ophthalmol 97 2013 460 465
13. A.A. Moshfeghi, P.J. Rosenfeld, H.W. Flynn, S.G. Schwartz, J.L. Davis, and T.G. Murray et al. Endophthalmitis after intravitreal vascular [corrected] endothelial growth factor antagonists: a six-year experience at a university referral center Retina 31 2011 662 668
14. T. Diago, C.A. McCannel, S.J. Bakri, J.S. Pulido, A.O. Edwards, and J.M. Pach Infectious endophthalmitis after intravitreal injection of antiangiogenic agents Retina 29 2009 601 605
15. A.R. Bhavsar, J.M. Googe, C.R. Stockdale, N.M. Bressler, A.J. Brucker, and M.J. Elman et al. Risk of endophthalmitis after intravitreal drug injection when topical antibiotics are not required: the diabetic retinopathy clinical research network laser-ranibizumab-triamcinolone clinical trials Arch Ophthalmol 127 2009 1581 1583
16. A.R. Bhavsar, C.R. Stockdale, F.L. Ferris, A.J. Brucker, N.M. Bressler, and A.R. Glassman Update on risk of endophthalmitis after intravitreal drug injections and potential impact of elimination of topical antibiotics Arch Ophthalmol 130 2012 809 810
17. S.S. Bhatt, K.E. Stepien, and K. Joshi Prophylactic antibiotic use after intravitreal injection: effect on endophthalmitis rate Retina 31 2011 2032 2036
18. A.P. Schachat, P.J. Rosenfeld, T.J. Liesegang, and M.W. Stewart Endophthalmitis is not a "never event" Ophthalmology 119 2012 1507 1508
19. R.L. Berkelman, B.W. Holland, and R.L. Anderson Increased bactericidal activity of dilute preparations of povidone-iodine solutions J Clin Microbiol 15 1982 635 639
20. Y. Ikuno, M. Sawa, M. Tsujikawa, F. Gomi, N. Maeda, and K. Nishida Effectiveness of 1.25% povidone-iodine combined with topical levofloxacin against conjunctival flora in intravitreal injection Jpn J Ophthalmol 56 2012 497 501
21. H. Shimada, S. Arai, H. Nakashizuka, T. Hattori, and M. Yuzawa Reduction of anterior chamber contamination rate after cataract surgery by intraoperative surface irrigation with 0.25% povidone-iodine Am J Ophthalmol 151 2011 11 17
22. H. Shimada, T. Hattori, R. Mori, H. Nakashizuka, K. Fujita, and M. Yuzawa Minimizing the endophthalmitis rate following intravitreal injections using 0.25% povidone-iodine irrigation and surgical mask Graefes Arch Clin Exp Ophthalmol 251 2013 1885 1890
23. J. Jiang, M. Wu, and T. Shen The toxic effect of different concentrations of povidone iodine on the rabbit's cornea Cutan Ocul Toxicol 28 2009 119 124
24. A.W. Ferguson, J.A. Scott, J. Mcgavigan, R.A. Elton, J. Mclean, and U. Schmidt et al. Comparison of 5% povidone-iodine solution against 1% povidone-iodine solution in preoperative cataract surgery antisepsis: a prospective randomised double blind study Br J Ophthalmol 87 2003 163 167
25. O. Halachmi-Eyal, Y. Lang, Y. Keness, and D. Miron Preoperative topical moxifloxacin 0.5% and povidone-iodine 5.0% versus povidone-iodine 5.0% alone to reduce bacterial colonization in the conjunctival sac J Cataract Refract Surg 35 2009 2109 2114
26. J.M. Moss, S.R. Sanislo, and C.N. Ta A prospective randomized evaluation of topical gatifloxacin on conjunctival flora in patients undergoing intravitreal injections Ophthalmology 116 2009 1498 1501
27. P. Costello, S.J. Bakri, P.M. Beer, R.J. Singh, N.S. Falk, and G.B. Peters et al. Vitreous penetration of topical moxifloxacin and gatifloxacin in humans Retina 26 2006 191 195
28. S.B. Dave, H.S. Toma, and S.J. Kim Ophthalmic antibiotic use and multidrug-resistant Staphylococcus epidermidis: a controlled, longitudinal study Ophthalmology 118 2011 2035 2040
29. R.E. Fintelmann, E.N. Hoskins, T.M. Lietman, J.D. Keenan, B.D. Gaynor, and V. Cevallos et al. Topical fluoroquinolone use as a risk factor for in vitro fluoroquinolone resistance in ocular cultures Arch Ophthalmol 129 2011 399 402
30. W. Haas, C.M. Pillar, M. Torres, T.W. Morris, and D.F. Sahm Monitoring antibiotic resistance in ocular microorganisms: results from the Antibiotic Resistance Monitoring in Ocular micRorganisms (ARMOR) 2009 surveillance study Am J Ophthalmol 152 2011 567 574
31. E. Milder, J. Vander, C. Shah, and S. Garg Changes in antibiotic resistance patterns of conjunctival flora due to repeated use of topical antibiotics after intravitreal injection Ophthalmology 119 2012 1420 1424
32. D. Miller, P.M. Flynn, I.U. Scott, E.C. Alfonso, and H.W. Flynn In vitro fluoroquinolone resistance in staphylococcal endophthalmitis isolates Arch Ophthalmol 124 2006 479 483
33. S.J. Kim, and H.S. Toma Antimicrobial resistance and ophthalmic antibiotics: 1-year results of a longitudinal controlled study of patients undergoing intravitreal injections Arch Ophthalmol 129 2011 1180 1188
34. V.T. Yin, D.J. Weisbrod, K.T. Eng, C. Schwartz, R. Kohly, and E. Mandelcorn et al. Antibiotic resistance of ocular surface flora with repeated use of a topical antibiotic after intravitreal injection JAMA Ophthalmol 131 2013 456 461
35. C.R. Alabiad, D. Miller, J.C. Schiffman, and J.L. Davis Antimicrobial resistance profiles of ocular and nasal flora in patients undergoing intravitreal injections Am J Ophthalmol 152 2011 999 1004
36. S.J. Kim, and H.S. Toma Ophthalmic antibiotics and antimicrobial resistance a randomized, controlled study of patients undergoing intravitreal injections Ophthalmology 118 2011 1358 1363
37. S.J. Kim, H.S. Toma, N.K. Midha, E.F. Cherney, F.M. Recchia, and T.J. Doherty Antibiotic resistance of conjunctiva and nasopharynx evaluation study: a prospective study of patients undergoing intravitreal injections Ophthalmology 117 2010 2372 2378
38. R.R. Doshi, T. Leng, and A.E. Fung Reducing oral flora contamination of intravitreal injections with face mask or silence Retina 32 2012 473 476
39. J.C. Wen, C.A. McCannel, A.B. Mochon, and O.B. Garner Bacterial dispersal associated with speech in the setting of intravitreous injections Arch Ophthalmol 129 2011 1551 1554
40. R.G. Abell, N.M. Kerr, P. Allen, and B.J. Vote Intravitreal injections: is there benefit for a theatre setting? Br J Ophthalmol 96 2012 1474 1478
41. Z.D. Inman, and N.G. Anderson Incidence of endophthalmitis after intravitreal injection of antivascular endothelial growth factor medications using topical lidocaine gel anesthesia Retina 31 2011 669 672
42. D.A. Lyall, A. Tey, B. Foot, S.T. Roxburgh, M. Virdi, and C. Robertson et al. Post-intravitreal anti-VEGF endophthalmitis in the United Kingdom: incidence, features, risk factors, and outcomes Eye (Lond) 26 2012 1517 1526
43. P. Romero-Aroca, L. Sararols, L. Arias, R.P. Casaroli-Marano, and F. Bassaganyas Topical azithromycin or ofloxacin for endophthalmitis prophylaxis after intravitreal injection Clin Ophthalmol 6 2012 1595 1599
44. M.W. Stewart, and M.L. Stewart Topical azithromycin or ofloxacin for endophthalmitis Clin Ophthalmol 7 2013 35 36
45. G. Ratnarajan, R. Nath, S. Appaswamy, and S.L. Watson Intravitreal injections using a novel conjunctival mould: a comparison with a conventional technique Br J Ophthalmol 97 2013 395 397